Text Size

Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Abhijeet Basoor, St. Joseph Mercy Oakland Hospital
ClinicalTrials.gov Identifier:
NCT01446536
First received: September 30, 2011
Last updated: March 18, 2012
Last verified: March 2012
History of Changes

September 30, 2011
March 18, 2012
August 2008
June 2010   (final data collection date for primary outcome measure)
  • Readmissions [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    Readmission to the hospital for CHF within 6 months of discharge
  • Dose titration [ Time Frame: patients were followed during the time of hospital stay, average of 5 days ] [ Designated as safety issue: No ]
    up titration of medications including Beta blocer, ACE inhibitor or ARB was assessed during the hospital stay
Same as current
Complete list of historical versions of study NCT01446536 on ClinicalTrials.gov Archive Site
Medications prescribed [ Time Frame: patients were followed during their hospital stay from admission to discharge, on an average of 5 days ] [ Designated as safety issue: No ]
during the hospital stay and at discharge this outcome is measured/assessed
Same as current
Not Provided
Not Provided
 
Effect of Quality Improvement Tools in Congestive Heart Failure (CHF)
Decreased Readmissions and Improved Quality of Care With Use of Inexpensive Checklist in Heart Failure

Hypothesis: Quality Improvement tools like "Heart Failure Discharge Checklist" which emphasizes on proper education to patients, ensure appropriate dose titration and counselling improve outcome in congestive heart failure (CHF).
Not Provided
Interventional
Not Provided
Masking: Single Blind (Investigator)
Congestive Heart Failure
Other: Checklist cohort
CHF discharge checklist was used arbitrarily by their treating physicians in addition to the standard therapy
  • No Intervention: Control group
    This arm which was control group, was randomly selected among patients with acute decompensated heart failure in whom the checklist was not used. This group was managed as per the standard guidelines.
  • Active Comparator: Checklist (intervention) cohort
    checklist was used in this group arbitrarily by their treating physician
    Intervention: Other: Checklist cohort
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
96
June 2010
June 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients admitted to SJMO with principal diagnosis of acute decompensated heart failure

Exclusion Criteria:

  • Age less than 18 years
  • Pregnant women
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01446536
11-09-02
Not Provided
Abhijeet Basoor, St. Joseph Mercy Oakland Hospital
St. Joseph Mercy Oakland Hospital
Not Provided
Principal Investigator: Abhijeet Basoor, MD St. Joseph Mercy Oakland Hospital
St. Joseph Mercy Oakland Hospital
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP